The goliath retail pharmacy company is replacing General Electric in a key stock market index.
The nation's biggest supplier of wind turbine blades just caught a tailwind.
Rumors are flying that big pharma could make a bid for Tesaro.
MoviePass is not the only game in town.
Investors are piling into gene therapy stocks today, causing Sangamo's shares to take flight.
Disney just drastically increased its bid for the entertainment conglomerate. Here's what investors need to know.
Shares of the RV maker moved higher on an impressive earnings report.
The marijuana stock is now up 353% in the last year.
The space company's shares are rocketing following an analyst upgrade.
The company confirmed that it's in talks to sell itself.
Shares dropped after the company reported data from a late-stage trial. Here's what investors need to know.
Welcome to biotech investing.
CVS Health is introducing a new service that's got investors seeing green.
Sarepta's experimental gene therapy could be a game-changer for patients with Duchenne muscular dystrophy.
Investors proceed with caution amid some mishaps at Tesla's factory.
An analyst thinks the stock has gone too far too fast.
The healthcare payment-solutions specialist is being acquired. Here's what investors need to know.
A Street analyst cut his estimates on the Snapchat operator.
The company's being acquired by long-time partner Roche Holdings.
The meteoric rise in recent weeks is proving unsustainable.